Dataset Information

Facile Fabrication of Flocculent Magnesium Silicate for the Adsorption of Oxytetracycline.

ABSTRACT: The discharge of antibiotics and the potential threat to organisms posed by this have received increasing attention. In this work, flocculent magnesium silicate (FMS) was fabricated by a facile hydrothermal and freeze-drying process, and its adsorption behavior for antibiotic oxytetracycline (OTC) was investigated. FMS presented a sepiolite-type structure and the alkaline solution promoted its hydroxylation. A hierarchical pore structure ranging from micropores to macropores and a high specific surface area of 660 m²/g were exhibited. FMS exhibited a higher adsorption amount in neutral solution than in acidic or alkaline conditions as the physicochemical properties of FMS and OTC were significantly affected by the pH. Adsorption isotherm could be well-described by the Langmuir model, and the calculated saturated adsorption capacity was as high as 265 mg/g. Adsorption kinetics followed the pseudo-second-order kinetic model, and the adsorption rate-controlling step was intraparticle diffusion. Thermodynamic parameters indicated that the adsorption was a spontaneous physicochemical reaction. After five cycles, around 91% of the adsorption performance was still maintained, demonstrating the excellent reusability of FMS. The sepiolite-type FMS fabricated in this work could be applied to remove OTC from wastewater.

SUBMITTER: Sun Z

PROVIDER: S-EPMC7408182 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Facile Fabrication of Flocculent Magnesium Silicate for the Adsorption of Oxytetracycline.

Sun Zhiwei Z Liu Yanhua Y

ACS omega 20200722 30

The discharge of antibiotics and the potential threat to organisms posed by this have received increasing attention. In this work, flocculent magnesium silicate (FMS) was fabricated by a facile hydrothermal and freeze-drying process, and its adsorption behavior for antibiotic oxytetracycline (OTC) was investigated. FMS presented a sepiolite-type structure and the alkaline solution promoted its hydroxylation. A hierarchical pore structure ranging from micropores to macropores and a high specific ...[more]

PMID: 32775912

Similar Datasets

Project description:The EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) provides a scientific opinion re-evaluating the safety of calcium silicate (E 552), magnesium silicate (E 553a) and talc (E 553b) when used as food additives. In 1991, the Scientific Committee on Food (SCF) established a group acceptable daily intake (ADI) 'not specified' for silicon dioxide and silicates. The EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) recently provided a scientific opinion re-evaluating the safety of silicon dioxide (E 551) when used as a food additive. The Panel noted that the absorption of silicates and talc was very low; there was no indication for genotoxicity or developmental toxicity for calcium and magnesium silicate and talc; and no confirmed cases of kidney effects have been found in the EudraVigilance database despite the wide and long-term use of high doses of magnesium trisilicate up to 4 g/person per day over decades. However, the Panel considered that accumulation of silicon from calcium silicate in the kidney and liver was reported in rats, and reliable data on subchronic and chronic toxicity, carcinogenicity and reproductive toxicity of silicates and talc were lacking. Therefore, the Panel concluded that the safety of calcium silicate (E 552), magnesium silicate (E 553a(i)), magnesium trisilicate (E 553a(ii)) and talc (E 553b) when used as food additives cannot be assessed. The Panel considered that there is no mechanistic rationale for a group ADI for silicates and silicon dioxide and the group ADI established by the SCF is obsolete. Based on the food supplement scenario considered as the most representative for risk characterisation, exposure to silicates (E 552-553) for all population groups was below the maximum daily dose of magnesium trisilicate used as an antacid (4 g/person per day). The Panel noted that there were a number of approaches, which could decrease the uncertainties in the current toxicological database. These approaches include - but are not limited to - toxicological studies as recommended for a Tier 1 approach as described in the EFSA Guidance for the submission of food additives and conducted with an adequately characterised material. Some recommendations for the revision of the EU specifications were proposed by the Panel.

Dataset Information

Facile Fabrication of Flocculent Magnesium Silicate for the Adsorption of Oxytetracycline.

Publications

Facile Fabrication of Flocculent Magnesium Silicate for the Adsorption of Oxytetracycline.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure